Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-005852

Yarrow Bioscience, Inc. · YARW

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Jan 29, 2018
Accepted (ET)
Jan 29, 2018 · 4:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001566044

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jan 29, 2018C2,584—A1,418,005IBy Presidio Partners 2007, L.P.
Common StockF1,F2Jan 29, 2018C66—A36,358IBy Presidio Partners 2007 (Parallel), L.P.
Common StockF1,F2Jan 29, 2018C849,794—A2,267,799IBy Presidio Partners 2007, L.P.
Common StockF1,F3Jan 29, 2018C21,789—A58,147IBy Presidio Partners 2007 (Parallel), L.P.
Common StockF1,F3Jan 29, 2018C127,269—A2,395,068IBy Presidio Partners 2007, L.P.
Common StockF1,F3Jan 29, 2018C3,263—A61,410IBy Presidio Partners 2007 (Parallel), L.P.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series A Preferred StockF1—Jan 29, 2018C6,971D——Common Stock2,5840I
Series A Preferred StockF1—Jan 29, 2018C179D——Common Stock660I
Series B Preferred StockF3,F1—Jan 29, 2018C2,292,320D——Common Stock849,7940I
Series B Preferred StockF3,F1—Jan 29, 2018C58,777D——Common Stock21,7890I
Series C Preferred StockF3,F1—Jan 29, 2018C343,310D——Common Stock127,2690I
Series C Preferred StockF3,F1—Jan 29, 2018C21,789D——Common Stock3,2630I

Explanation of responses